These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7491816

  • 1. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2.
    Johnson BJ, Sviat SL, Happ CM, Dunn JJ, Frantz JC, Mayer LW, Piesman J.
    Vaccine; 1995 Aug; 13(12):1086-94. PubMed ID: 7491816
    [Abstract] [Full Text] [Related]

  • 2. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
    Kurtenbach K, Dizij A, Voet P, Hauser P, Simon MM.
    Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
    [Abstract] [Full Text] [Related]

  • 3. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF, Appel MJ, Jacobson RH, Shin SJ, Harpending P, Straubinger R, Patrican LA, Mohammed H, Summers BA.
    Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
    [Abstract] [Full Text] [Related]

  • 4. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang Y, Novosol V, McDonough SP, Chang CF, Jacobson RH, Divers T, Quimby FW, Shin S, Lein DH.
    Vaccine; 1999 Oct 14; 18(5-6):540-8. PubMed ID: 10519945
    [Abstract] [Full Text] [Related]

  • 5. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
    Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, Capiau C, Desmons P, Voet P, Dearwester D, Frantz JC.
    Infect Immun; 1997 Mar 14; 65(3):882-9. PubMed ID: 9038292
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.
    J Immunol; 2001 Jun 15; 166(12):7398-403. PubMed ID: 11390491
    [Abstract] [Full Text] [Related]

  • 7. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins.
    Kurtti TJ, Munderloh UG, Hughes CA, Engstrom SM, Johnson RC.
    Infect Immun; 1996 Oct 15; 64(10):4148-53. PubMed ID: 8926082
    [Abstract] [Full Text] [Related]

  • 8. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W, Gern L, Kramer M, Wallich R, Simon MM.
    Eur J Immunol; 1997 Nov 15; 27(11):2942-7. PubMed ID: 9394822
    [Abstract] [Full Text] [Related]

  • 9. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul 15; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 10. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR, Oliver LD, Earnhart CG, Marconi RT.
    Vaccine; 2017 May 31; 35(24):3178-3185. PubMed ID: 28479174
    [Abstract] [Full Text] [Related]

  • 11. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT, Burkot TR, Piesman J, Dolan MC, Capiau C, Hauser P, Dequesne G, Lobet Y.
    Vaccine; 1995 Apr 31; 13(5):435-41. PubMed ID: 7639011
    [Abstract] [Full Text] [Related]

  • 12. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.
    Gern L, Rais O, Capiau C, Hauser P, Lobet Y, Simoen E, Voet P, Pêtre J.
    Immunol Lett; 1994 Mar 31; 39(3):249-58. PubMed ID: 8034340
    [Abstract] [Full Text] [Related]

  • 13. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
    de Silva AM, Zeidner NS, Zhang Y, Dolan MC, Piesman J, Fikrig E.
    Infect Immun; 1999 Jan 31; 67(1):30-5. PubMed ID: 9864192
    [Abstract] [Full Text] [Related]

  • 14. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
    Lovrich SD, Callister SM, DuChateau BK, Lim LC, Winfrey J, Day SP, Schell RF.
    Infect Immun; 1995 Jun 31; 63(6):2113-9. PubMed ID: 7768589
    [Abstract] [Full Text] [Related]

  • 15. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997 Jun 31; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.
    Padilla ML, Callister SM, Schell RF, Bryant GL, Jobe DA, Lovrich SD, DuChateau BK, Jensen JR.
    J Infect Dis; 1996 Oct 31; 174(4):739-46. PubMed ID: 8843211
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model.
    Schwendinger MG, O'Rourke M, Traweger A, Savidis-Dacho H, Pilz A, Portsmouth D, Livey I, Barrett PN, Crowe BA.
    PLoS One; 2013 Oct 31; 8(11):e79022. PubMed ID: 24260146
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.
    Jensen JR, Du Chateau BK, Munson EL, Callister SM, Schell RF.
    Infect Immun; 1998 Apr 31; 66(4):1507-12. PubMed ID: 9529074
    [Abstract] [Full Text] [Related]

  • 19. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
    de Silva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E.
    J Exp Med; 1996 Jan 01; 183(1):271-5. PubMed ID: 8551231
    [Abstract] [Full Text] [Related]

  • 20. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
    Coughlin RT, Fish D, Mather TN, Ma J, Pavia C, Bulger P.
    J Infect Dis; 1995 Apr 01; 171(4):1049-52. PubMed ID: 7706788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.